Early last Saturday, nurses at an Indianapolis hospital went to the drug cabinet in the newborn intensive care unit to get blood-thinner for several premature babies. The nurses didn't realize a ...

Deerfield, IL - Baxter International is now recalling from the market all remaining lots and doses of its heparin sodium multidose and single-dose vials for injection and its heparin lock flush ...

In addition to the previously recalled lots of heparin sodium injection 1000 units/mL 10mL and 30mL multi- dose vials, Baxter's recall will now include the remaining lots of those products and heparin ...

Getting your Trinity Audio player ready... INDIANAPOLIS- Early last Saturday, nurses at an Indianapolis hospital went to the drug cabinet in the newborn intensive care unit to get blood-thinner for ...

Early last Saturday, nurses at an Indianapolis hospital went to the drug cabinet in the newborn intensive care unit to get blood-thinner for several premature babies. The nurses didn't realize a ...

SCHAUMBURG, Ill.--(BUSINESS WIRE)--APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ:APCVZ), announced today that it has received clearance ...

Taurolidine is an antibacterial and antifungal agent with a mechanism of action that is less prone to development of antimicrobial resistance. A taurolidine/heparin lock solution carries a lower risk ...

This is the first FDA-approved antimicrobial catheter lock solution. The FDA has approved taurolidine plus heparin (DefenCath®) catheter lock solution to reduce catheter-related bloodstream infections ...

Early last Saturday nurses at an Indianapolis hospital went to the drug cabinet in the newborn intensive care unit to get blood-thinner for several premature babies. The nurses didn't realize a ...

A mass recall of heparin has health-care providers concerned about supplies of the blood thinner that is used to clear intravenous lines and prevent clots in surgical and dialysis patients. Baxter ...

A study published in Clinical Infectious Diseases examined the cost-effectiveness of antimicrobial locks for the prevention of central line-associated bloodstream infections. Antibiotic lock therapy ...